<article>Indian eye care hospital chain <a href="http://dealstreetasia.com/tag/dr-agarwal" target="_blank" rel="noopener">Dr. Agarwal’s Healthcare Ltd </a>has raised Rs. 270 crore (around $38 million) from Singapore-based investment firm <a href="http://dealstreetasia.com/tag/temasek" target="_blank" rel="noopener">Temasek</a>, according to an official statement.</article>

Indian eye care hospital chain <a href="http://dealstreetasia.com/tag/dr-agarwal" target="_blank" rel="noopener">Dr. Agarwal’s Healthcare Ltd </a>has raised Rs. 270 crore (around $38 million) from Singapore-based investment firm <a href="http://dealstreetasia.com/tag/temasek" target="_blank" rel="noopener">Temasek</a>, according to an official statement.
The healthcare firm plans to use the funds raised from Temasek to expand its geographical presence as well as in making significant investments in latest technology for super specialty eye-care.
Dr. Agarwal’s plans to add around  50-75 hospitals to its network over the next three to five years with a major focus on metro cities as well as tier 2 and tier 3 towns.
&#8220;We believe their (Temasek)&#8217;s expertise and support will help our company expand our network of clinics and operations to better meet the growing demand for affordable and quality eye care across India.” said Dr. Agarwal’s Group chairman Amar Agarwal.
Currently the hospital chain has 76 hospitals with 62 centres across 12 states in India and 14 hospitals in 10 countries of Africa.
&#8220;The expansion will be done through a mix of strategic partnerships, acquisitions and greenfield hospitals. Innovation and technology will continue to be at the forefront of our growth, and we will be investing more in cutting edge technology such as SMILE, FemtoLaser and Robotic Cataract Surgery across our centres,&#8221; he added.
In 2016, Hong Kong-based private equity player <a href="http://dealstreetasia.com/tag/adv-partners" target="_blank" rel="noopener">ADV Partners</a> invested Rs 270 crores in Dr Agarwal’s HealthCare Ltd giving the investor a seat on the company&#8217;s board. Subsequently, it had also raised Rs 160 crore in structured debt from the second Special Opportunities Fund of Edelweiss in July 2017.
Mid-market investment bank Veda Corporate Advisors advised the company on the transaction.
It was reported last year that Indian private equity fund ChrysCapital was in advanced talks to acquire a minority stake in Chennai-based Dr Agarwal’s Health Care Ltd for about Rs 200-250 crore.
For the quarter ended December 31, 2018 public-listed Dr Agarwal&#8217;s had reported revenue of Rs 41 crore, with net profit of Rs 1.2 crore.
Temasek has been an active investor in India with a portfolio of over $10 billion in the country. Early last year it had disclosed making  an average yearly investment of $1 billion in the last five years. The investment firm&#8217;s healthcare portfolio in India includes investments in Medanta MediCity, Manipal Hospitals and HealthCare Global.
Temasek&#8217;s major investments in other sectors in the country last year include $250 million in IT firm UST Global, $125 million in digital payment platform Pine Labs along with PayPal, and $147 million (Rs 1,000 crore) in AU Small Finance Bank.
Also Read:
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/chryscapital-emami-complan-dlf-gic-105043/" target="_blank" rel="noopener">ChrysCapital eyes Dr Agarwal’s Health Care</a>
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/dr-agarwals-health-care-edelweiss-fund-76815/" target="_blank" rel="noopener">India: Dr Agarwal’s Health Care said to raise $25m from Edelweiss Fund</a>

Indian eye care hospital chain Dr. Agarwal’s Healthcare Ltd has raised Rs. 270 crore (around $38 million) from Singapore-based investment firm Temasek.

Singapore's Temasek invests $38m in Indian eyecare chain Dr. Agarwal’s

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Singapore's Temasek invests $38m in Indian eyecare chain Dr. Agarwal’s

Start your deal-making journey now!

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief